Analysts Set GE HealthCare Technologies Inc. (NASDAQ:GEHC) Price Target at $86.89

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have been assigned a consensus rating of “Moderate Buy” from the eleven brokerages that are covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $85.7778.

A number of analysts have weighed in on the company. Morgan Stanley set a $74.00 target price on GE HealthCare Technologies in a research note on Thursday, September 18th. Weiss Ratings reissued a “hold (c)” rating on shares of GE HealthCare Technologies in a research report on Saturday, September 27th. BTIG Research reissued a “buy” rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Citigroup downgraded GE HealthCare Technologies from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $93.00 to $83.00 in a research report on Tuesday. Finally, Wall Street Zen downgraded GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th.

Hedge Funds Weigh In On GE HealthCare Technologies

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Wynn Capital LLC grew its position in shares of GE HealthCare Technologies by 4.6% during the 3rd quarter. Wynn Capital LLC now owns 4,266 shares of the company’s stock worth $320,000 after buying an additional 189 shares in the last quarter. Northside Capital Management LLC boosted its position in GE HealthCare Technologies by 76.4% during the third quarter. Northside Capital Management LLC now owns 140,507 shares of the company’s stock valued at $10,552,000 after purchasing an additional 60,852 shares in the last quarter. Canandaigua National Bank & Trust Co. bought a new stake in GE HealthCare Technologies during the third quarter valued at about $230,000. Salem Investment Counselors Inc. boosted its position in GE HealthCare Technologies by 31.1% during the third quarter. Salem Investment Counselors Inc. now owns 161,585 shares of the company’s stock valued at $12,135,000 after purchasing an additional 38,369 shares in the last quarter. Finally, Moody National Bank Trust Division boosted its position in GE HealthCare Technologies by 9.0% during the third quarter. Moody National Bank Trust Division now owns 13,540 shares of the company’s stock valued at $1,017,000 after purchasing an additional 1,119 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

GEHC stock opened at $74.49 on Friday. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. The business’s fifty day simple moving average is $74.15 and its two-hundred day simple moving average is $72.46. GE HealthCare Technologies has a twelve month low of $57.65 and a twelve month high of $94.80. The firm has a market cap of $34.01 billion, a price-to-earnings ratio of 15.26, a PEG ratio of 2.92 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same quarter last year, the firm posted $1.00 earnings per share. The business’s revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Analysts predict that GE HealthCare Technologies will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 2.87%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.